OncoPaC-1: An Open-label, Single-Arm Pilot Study of Phosphorus-32 Microparticles Brachytherapy in Combination with Gemcitabine +/- Nab-Paclitaxel in Unresectable Locally Advanced Pancreatic Cancer

Open Label

An open-label, single-arm pilot study of EUS-guided brachytherapy with phosphorus-32 microparticles in combination with gemcitabine +/- nab-paclitaxel in unresectable locally advanced pancreatic cancer (OncoPaC-1): Technical details and study protocol

Endoscopic Ultrasound ◽

10.4103/eus.eus_44_19 ◽

2020 ◽

Vol 9 (1) ◽

pp. 24 ◽

Cited By ~ 2

Author(s):

ManoopS Bhutani ◽

JosephM Herman ◽

JasonB Klapman ◽

Richard Tuli ◽

Ghassan El-Haddad ◽

...

Keyword(s):

Pancreatic Cancer ◽

Pilot Study ◽

Study Protocol ◽

Locally Advanced ◽

Open Label ◽

Technical Details

PanCO: Updated Results of an Open-Label, Single-Arm Pilot Study of OncoSil P-32 Microparticles in Combination with Standard-of-Care (SoC) Gemcitabine + Nab-Paclitaxel or FOLFIRINOX Chemotherapy in Unresectable Locally Advanced Pancreatic Cancer (uLAPC)

Pancreatology ◽

10.1016/j.pan.2020.10.007 ◽

2020 ◽

Vol 20 (8) ◽

pp. e16

Author(s):

Paul Ross ◽

Alain Hendlisz ◽

Thankamma Ajithkumar ◽

Chinenye Iwuji ◽

Marion Harris ◽

...

Keyword(s):

Pancreatic Cancer ◽

Pilot Study ◽

Locally Advanced ◽

Standard Of Care ◽

Open Label

Maintenance therapy with alpha-interferon (IFN-α) in locally advanced pancreatic cancer (LAPC): A pilot study

Pancreatology ◽

10.1016/j.pan.2012.11.194 ◽

2012 ◽

Vol 12 (6) ◽

pp. 558-559

Author(s):

S. Cereda ◽

A. Rognone ◽

C. Belli ◽

P. Passoni ◽

N. Slim ◽

...

Keyword(s):

Pancreatic Cancer ◽

Pilot Study ◽

Maintenance Therapy ◽

Locally Advanced ◽

Alpha Interferon

Nab-paclitaxel plus gemcitabine in patients with locally advanced pancreatic cancer (LAPACT): a multicentre, open-label phase 2 study

The Lancet Gastroenterology & Hepatology ◽

10.1016/s2468-1253(19)30327-9 ◽

2020 ◽

Vol 5 (3) ◽

pp. 285-294 ◽

Cited By ~ 14

Author(s):

Philip A Philip ◽

Jill Lacy ◽

Fabienne Portales ◽

Alberto Sobrero ◽

Roberto Pazo-Cid ◽

...

Keyword(s):

Pancreatic Cancer ◽

Locally Advanced ◽

Phase 2 ◽

Open Label ◽

Phase 2 Study ◽

Open Label Phase

Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial

The Lancet Oncology ◽

10.1016/s1470-2045(16)00078-4 ◽

2016 ◽

Vol 17 (5) ◽

pp. 651-662 ◽

Cited By ~ 243

Author(s):

Timothy M Nywening ◽

Andrea Wang-Gillam ◽

Dominic E Sanford ◽

Brian A Belt ◽

Roheena Z Panni ◽

...

Keyword(s):

Pancreatic Cancer ◽

Locally Advanced ◽

Dose Finding ◽

Single Centre ◽

Open Label ◽

Borderline Resectable ◽

Label Dose ◽

Phase 1B

Nutritional status of patients with locally advanced pancreatic cancer: a pilot study

Supportive Care in Cancer ◽

10.1007/s00520-010-1011-x ◽

2010 ◽

Vol 19 (11) ◽

pp. 1729-1734 ◽

Cited By ~ 19

Author(s):

Leah M. Ferrucci ◽

Diana Bell ◽

Jennifer Thornton ◽

Glenda Black ◽

Ruth McCorkle ◽

...

Keyword(s):

Pancreatic Cancer ◽

Pilot Study ◽

Nutritional Status ◽

Locally Advanced ◽

Locally Advanced Pancreatic Cancer

Nab-paclitaxel plus gemcitabine in patients with locally advanced pancreatic cancer: A multicenter open-label cohort study (NABGEM cohort study)

Pancreatology ◽

10.1016/j.pan.2021.05.226 ◽

2021 ◽

Vol 21 ◽

pp. S83

Author(s):

L. Brada ◽

M. Walma ◽

N. Haj Mohammad ◽

H. Pruijt ◽

J. de Vos-Geelen ◽

...

Keyword(s):

Pancreatic Cancer ◽

Cohort Study ◽

Locally Advanced ◽

Open Label

A pilot study of oxaliplatin, irinotecan and PK-adjusted 5-fluorouracil within a neoadjuvant multidisciplinary approach in locally advanced pancreatic cancer patients.

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.e15220 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. e15220-e15220

Author(s):

Patricia Martin Romano ◽

Azucena Aldaz ◽

Ana Chopitea ◽

Fernando Pardo ◽

Leire Arbea ◽

...

Keyword(s):

Pancreatic Cancer ◽

Pilot Study ◽

Cancer Patients ◽

Multidisciplinary Approach ◽

Locally Advanced ◽

Locally Advanced Pancreatic Cancer

P-260 Naïve indirect treatment comparison of PanCO, a pilot study of OncoSil P-32 microparticles combined with gemcitabine + nab-paclitaxel or FOLFIRINOX chemotherapy versus standard-of-care treatment in unresectable locally advanced pancreatic cancer

Annals of Oncology ◽

10.1016/j.annonc.2020.04.342 ◽

2020 ◽

Vol 31 ◽

pp. S174-S175

Author(s):

S. Allerdice ◽

N. Wilson ◽

D. Turner ◽

P. McCloud ◽

D. Kenny ◽

...

Keyword(s):

Pancreatic Cancer ◽

Pilot Study ◽

Locally Advanced ◽

Standard Of Care ◽

Indirect Treatment Comparison ◽

Treatment Comparison ◽

Standard Of Care Treatment ◽

Indirect Treatment

FOLFIRINOX-based neoadjuvant chemoradiotherapy for borderline and locally advanced pancreatic cancer: A pilot study from a tertiary centre

Digestive and Liver Disease ◽

10.1016/j.dld.2019.03.004 ◽

2019 ◽

Vol 51 (7) ◽

pp. 1043-1049 ◽

Cited By ~ 4

Author(s):

Claudia Pouypoudat ◽

Etienne Buscail ◽

Sébastien Cossin ◽

Christophe Cassinotto ◽

Eric Terrebonne ◽

...

Keyword(s):

Pancreatic Cancer ◽

Pilot Study ◽

Locally Advanced ◽

Neoadjuvant Chemoradiotherapy ◽

Tertiary Centre